Media

Media

Recent News

  • Avivagen Secures Approval for Use of OxC-beta™ Livestock in Brazil and Signs Distribution Agreement

    Ottawa, ON / Business Wire / June 24, 2020 / – Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”) a life sciences corporation focused on developing and commercializing immune-system improving products for livestock, companion animal and human applications, is pleased to announce that it has received approval from The Ministry of Agriculture-Feed Additives Division for the immediate use …Read More

  • Avivagen Inc. Announces Results for the Second Quarter Ending April 30, 2020

    Ottawa, ON /Business Wire/ June 2, 2020 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a world leader in natural alternatives to antibiotics with its OxC-beta™  technology, announces its unaudited financial results for the second quarter of 2020. For the three-month period ended April 30, 2020, the Corporation reported revenues of $29,625, a decrease …Read More

  • Avivagen Announces Increase in North American OxC-betaTM Livestock Order Following Successful Dairy Field Tests

    Industrias Melder revises initial order from 300 kgs to 2 tonnes Ottawa, ON /Business Wire/ May 20, 2020 / – Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”) a life sciences corporation focused on developing and commercializing immune-system improving products for livestock, companion animal and human applications, is pleased to announce that its North American purchase order for …Read More

  • Avivagen Announces Results From Its Annual General Meeting April 8, 2020

    Ottawa, ON / Business Wire / April 8, 2020 / – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”), announces that at the Corporation’s Annual General Meeting (AGM) held today the Corporation’s shareholders voted to support all of the resolutions that came before the meeting.  The resolutions included the reappointment of McGovern Hurley LLP as Avivagen’s auditor …Read More

  • Avivagen Secures Largest-Yet Order of OxC-beta™ Livestock

    Ottawa, ON /Business Wire/ April 07, 2020 / Avivagen Inc. (TSXV:VIV) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, has received its largest yet order for OxC-beta™ Livestock from UNAHCO, its long-standing …Read More

View All News Releases

Media Coverage

View All Media Coverage